Canadian Respiratory Journal (Jan 2008)

Effect of Maintenance Azithromycin on Established Bronchiolitis Obliterans Syndrome in Lung Transplant Patients

  • Nancy R Porhownik,
  • Wael Batobara,
  • Wayne Kepron,
  • Helmut W Unruh,
  • Zoheir Bshouty

DOI
https://doi.org/10.1155/2008/158681
Journal volume & issue
Vol. 15, no. 4
pp. 199 – 202

Abstract

Read online

BACKGROUND: Bronchiolitis obliterans syndrome (BOS), the main cause of late mortality following lung transplantation, is defined as an irreversible decline in forced expiratory volume in 1 s (FEV1).Previous studies using azithromycin for BOS in lung transplant patients have demonstrated a potential reversibility of the decline in FEV1.